Improvement in lipids after switch to boosted atazanavir or darunavir in children/adolescents with perinatally acquired HIV on older protease inhibitors: results from the Pediatric HIV/AIDS Cohort Study.
| Author | |
|---|---|
| Abstract |
:
Dyslipidaemia is common in perinatally HIV-infected (PHIV) youth receiving protease inhibitors (PIs). Few studies have evaluated longitudinal lipid changes in PHIV youth after switch to newer PIs. |
| Year of Publication |
:
2018
|
| Journal |
:
HIV medicine
|
| Volume |
:
19
|
| Issue |
:
3
|
| Number of Pages |
:
175-183
|
| ISSN Number |
:
1464-2662
|
| URL |
:
https://doi.org/10.1111/hiv.12566
|
| DOI |
:
10.1111/hiv.12566
|
| Short Title |
:
HIV Med
|
| Download citation |
